Rankings Machinery & automation Path2 Hydrogen
Path2 Hydrogen
A view of the same findings, not a new score. How it works
The model found several serious problems. That does not mean the stock will fall.
Biggest deductions
- Multiples vs peers−14
- Margin−12
- Liquidity and going-concern risk−10
Strengths
- First order from a public customer+1
Speculative profile
A penny stock under DKK 3. The asymmetry rating is separate from the Bjarvik score and is not a recommendation.
- Asymmetry (1–10)
- 2
- Price
- 1.64 DKK
- Market value
- DKK 183m
- Cash runway
- 12 months
- Cash / debt
- 0.1 / 11.1m EUR
- Dilution, 12 months
- +0%
Bull case
The first commercial pre-liquefier is delivered, GenH2 gets more orders for storage systems (buses, space, industry), and ProtonH2 shows cheap geological hydrogen. With revenue of EUR 10–15m in 2–3 years and EV/revenue 4–6, EV could reach EUR 40–90m; after debt and dilution of 30–50% that gives 1.5–3x – a 10x requires the ProtonH2 technology to work at large scale.
Bear case
Delivery of the first unit is delayed, the hydrogen market stays cold, and the major shareholder stops lending money. The cash (a few million EUR after leaseback) is burned in 1-1.5 years, and an issue at a very low price or an insolvency hits the few free shareholders. The AmeriMark stake at fair value may prove hard to realize.
Catalysts
- H2 2026Delivery and commissioning of the first commercial liquefaction unit (determines whether 2026 guidance holds)binary path2hydrogen.com
- 2026 (no date)Capital increase via authorized capital and new shareholder loansbinary path2hydrogen.com
- No dateExercise of the option to buy ProtonH2 (geological hydrogen), requires due diligence and shareholder approvalbinary pressetext.com
- No dateDelivery of a storage system to Golden Empire Transit and first projects with MP Industries in Europegradual globenewswire.com
How the score is built
From 100 to 24, step by step: points off for the business, the price and the cracks, back for documented strengths, then three data adjustments.
Hover or select a step to see what drove it. Steps with findings open them below.
Key numbers
As of 2 Nov 2026. Analyst targets tend to be optimistic; read upside as a hint, not a forecast.
- Price
- 0.27 EUR
- Median analyst target
- –
- Upside to median
- –
- Analysts
- none
- Target range
- –
- 52-week change
- −73%
- P/E (trailing)
- n/a
- Forward P/E
- n/a
- PEG
- n/a
Findings
Every deduction and every plus, with its source. Open a step to read them.
Business
Is the company getting stronger, not just bigger? · 4 findings−28 of −30
- −12MarginRevenue was only EUR 125,000 in H1 2026 (solely research collaborations, no product sales) vs EBITDA of −2.9m and a net loss of −EUR 3.9m; operating cash flow −3.0m in half a year.
- −7Quality of growthRevenue was EUR 365,000 in 2025 and 125,000 in H1 2026 (130,000 a year earlier); the first commercial liquefaction unit has not yet been delivered, and management itself writes that a delay means 2026 revenue will not exceed 2025 significantly. No quantitative guidance.
- −3MoatPatents on lossless storage of liquid hydrogen, but the market for liquefaction and cryogenic equipment is dominated by Air Liquide, Linde and Chart; the technology is not commercially proven at scale.
- −6Capital allocationComplex and unfocused structure: a listed shell with a 48% stake in a Swiss car-trading company (AmeriMark, EUR 24.8m at fair value), GenH2 via reverse takeover (93m shares, IFRS 2 expense of EUR 6.3m for the listing) and an option on ProtonH2; operations are financed with loans from major shareholders.
Price
Today's multiples against the company's own history and its peers. · 1 finding−14 of −35
- −14Multiples vs peersMarket cap EUR 24.5m vs equity attributable to parent shareholders of only 4.7m (P/B about 5) and annual revenue under 0.4m (P/S over 60). Listed hydrogen companies with real revenue typically trade at EV/revenue 1-5. No own history before 2025.
Cracks
Cash flow, customers, debt, insiders, guidance and what sits behind the headline numbers. · 5 findings−29 of −35
- −10Liquidity and going-concern riskCash was only EUR 91,000 at 30/6-2026; management calls liquidity the biggest, existence-threatening risk and writes that lack of financing 'could lead to insolvency'. Continued operations for 12 months rest on a loan commitment from the major shareholder and a sale-and-leaseback of the factory.
- −7Impending dilutionManagement expects a 'significantly higher capital raise' in 2026, including use of the authorized capital, and the ProtonH2 purchase may be paid in shares; with a market cap of EUR 24.5m even small issues will cause heavy dilution.
- −6Governance and controlThe largest shareholder H2E Americas LLC is also a lender (commitment raised from EUR 3m to 5m), Capana AG has lent money to both the parent company and AmeriMark, and the factory is sold and leased back; free float is very small, and one person makes up the entire executive board.
- −4Customer concentration and marketManagement describes the revenue base as 'highly concentrated' and the financing environment for early-stage hydrogen companies as challenging; the loss or delay of a single contract will hit hard.
- −2Price risk and liquidity in the stockThe price has fallen about 69-71% over 52 weeks (range EUR 0.165-1.00), and only about 10,000 shares (about EUR 2,000) trade per day.
Plus
Only documented strengths. · 1 finding+1 of +15
- +1First order from a public customerGenH2 and FASTECH have received a contract from Golden Empire Transit (Bakersfield, California) for a controlled storage system for liquid hydrogen for the bus fleet; a small but concrete commercial validation.
Caveats
What the score does not capture, or where the data is weak.
Also in Machinery & automation
The highest scores in the same industry.
